当前位置:首页 - 行情中心 - 特宝生物(688278) - 财务分析 - 现金流量表

特宝生物

(688278)

  

流通市值:211.93亿  总市值:211.93亿
流通股本:4.08亿   总股本:4.08亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,038,763,210.52983,596,732.233,370,745,401.212,454,222,650.87
  收到的税费返还2.31-1,053,779.861,053,779.86
  收到其他与经营活动有关的现金24,949,063.3616,455,316.2939,063,145.2830,954,046.75
  经营活动现金流入小计2,063,712,276.191,000,052,048.523,410,862,326.352,486,230,477.48
  购买商品、接受劳务支付的现金191,127,429.4362,984,102.21273,886,111.15186,343,062.41
  支付给职工以及为职工支付的现金677,814,455.76381,606,611.49947,436,617.8686,802,192.98
  支付的各项税费307,016,783.21153,223,681.09263,713,378.45191,176,718.99
  支付其他与经营活动有关的现金551,209,745.45267,855,445.971,196,450,350.09950,790,296.4
  经营活动现金流出小计1,727,168,413.85865,669,840.762,681,486,457.492,015,112,270.78
  经营活动产生的现金流量净额336,543,862.34134,382,207.76729,375,868.86471,118,206.7
二、投资活动产生的现金流量:
  收回投资收到的现金861,805,068.56601,931,826.711,559,427,565.981,047,638,167.17
  处置固定资产、无形资产和其他长期资产收回的现金净额1,986,382.98760745,790.5321,900
  收到的其他与投资活动有关的现金-9,215,949.87--
  投资活动现金流入小计863,791,451.54611,148,536.581,560,173,356.511,047,660,067.17
  购建固定资产、无形资产和其他长期资产支付的现金144,870,260.5974,873,480.2256,143,258.1168,636,047.19
  投资支付的现金477,000,000267,000,0001,745,966,623.841,178,394,721.08
  取得子公司及其他营业单位支付的现金--58,394,721.08-
  投资活动现金流出小计621,870,260.59341,873,480.22,060,504,603.021,347,030,768.27
  投资活动产生的现金流量净额241,921,190.95269,275,056.38-500,331,246.51-299,370,701.1
三、筹资活动产生的现金流量:
  吸收投资收到的现金--54,439,826.454,439,826.4
  取得借款收到的现金621,400,00041,500,000140,670,352.2120,000,000
  筹资活动现金流入小计621,400,00041,500,000195,110,178.6174,439,826.4
  偿还债务支付的现金23,592,924.2427,616,299.4--
  分配股利、利润或偿付利息支付的现金252,663,218.42613,691.66252,874,306.73252,387,208.33
  支付其他与筹资活动有关的现金608,501,313.673,417,140.179,393,732.255,970,558.54
  筹资活动现金流出小计884,757,456.3331,647,131.23262,268,038.98258,357,766.87
  筹资活动产生的现金流量净额-263,357,456.339,852,868.77-67,157,860.38-83,917,940.47
四、汇率变动对现金及现金等价物的影响-795,030.06-24,947.16-549,425.9-201,057.26
五、现金及现金等价物净增加额314,312,566.9413,485,185.75161,337,336.0787,628,507.87
  加:期初现金及现金等价物余额522,853,034.5522,853,034.5361,515,698.43361,515,698.43
  期末现金及现金等价物余额837,165,601.4936,338,220.25522,853,034.5449,144,206.3
补充资料:
  净利润476,526,946.01-1,031,236,252.58-
  固定资产和投资性房地产折旧44,667,448.91-67,097,292.45-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧44,667,448.91-67,097,292.45-
  无形资产摊销30,423,325.28-49,189,014.34-
  长期待摊费用摊销10,097,227.84-21,405,483.71-
  处置固定资产、无形资产和其他长期资产的损失-1,660,577.95-718,026.13-
  固定资产报废损失430,660.28-269,228.25-
  公允价值变动损失-509,982.19--3,448,015.83-
  财务费用2,480,833.42-1,971,417.52-
  投资损失-2,298,419.1--6,599,263.41-
  递延所得税-17,419,341.49--21,659,765.43-
  其中:递延所得税资产减少-17,442,547.87--28,422,780.7-
    递延所得税负债增加23,206.38-6,763,015.27-
  存货的减少-30,672,889.51--164,064,868.87-
  经营性应收项目的减少-142,450,609.91--405,579,582.89-
  经营性应付项目的增加-70,808,765.65-88,480,145.44-
  其他30,290,022.01-61,855,511.2-
  现金的期末余额837,165,601.4-522,853,034.5-
  减:现金的期初余额522,853,034.5-361,515,698.43-
  现金及现金等价物的净增加额314,312,566.9-161,337,336.07-
公告日期2026-08-192026-04-292026-03-272025-10-23
审计意见(境内)标准无保留意见
TOP↑